Evidence map›Paper›PMID 38680748›Full record

ArticleRadiology case reports2024

Pancreatic neuroendocrine tumor with solitary splenic metastasis and synchronous renal cell carcinoma: A rare case report.

Michael Teklehaimanot Abera, Yacob Sheiferawe Seman, Hidaya Yahya Mohammed, Fadil Nuredin Abrar, Admassu Melaku Mikru, Mahlet Kifle Mersha

Abstract readCase Reports
In one paragraph

Article in Radiology case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michael Teklehaimanot AberaAddis Ababa University, College of Health Sciences, Department of Radiology, Addis Ababa, Ethiopia.
Yacob Sheiferawe SemanAddis Ababa University, College of Health Sciences, Department of Urology, Addis Ababa, Ethiopia.
Hidaya Yahya MohammedAddis Ababa University, College of Health Sciences, Department of Pathology, Addis Ababa, Ethiopia.
Fadil Nuredin AbrarAddis Ababa University, College of Health Sciences, Department of Pathology, Addis Ababa, Ethiopia.
Admassu Melaku MikruAddis Ababa University, College of Health Sciences, Department of Urology, Addis Ababa, Ethiopia.
Mahlet Kifle MershaAddis Ababa University, College of Health Sciences, Department of Radiology, Addis Ababa, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synchronous pancreatic neuroendocrine tumors and renal cell cancer are extremely rare. Von-Hipple-Landau syndrome is a major association. A 43-year-old male patient with left upper quadrant pain and significant weight loss was diagnosed with a synchronous pancreatic tail neuroendocrine tumor with solitary splenic metastasis and a clear-cell renal cell carcinoma of the left kidney. Sonography and a computed tomography scan of the abdomen showed a complex exophytic left renal mass and a necrotic lesion limited to the spleen. Although not apparent on preoperative imaging, distal pancreatic mass was also discovered intraoperatively. Subsequently, left radical nephrectomy, splenectomy, and distal pancreatectomy were performed, and the synchronous primaries and splenic metastasis were confirmed histopathologically. This case is unique in that it demonstrates multiple extremely rare events occurring simultaneously, namely pancreatic and kidney primaries, as well as solitary splenic metastasis.

Indexed as

Computed tomographyPancreatic neuroendocrine tumorRenal cell carcinomaSolitary splenic metastasisSynchronous tumorsVon-Hippel-Lindau

Identifiers

PMID38680748
PMCPMC11046048

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.